Symptom-specific recipes: Ready-to-use blends for nausea, cravings, bloating, and energy dips
Transitioning to Phase 3
Identifying small-molecule agonists for class B1 GPCRs such as GLP-1R remains challenging due to the receptors conformational plasticity and its large, peptide-optimized binding interface (Liu et al., 2025)
The conversation around GLP-1 medications has exploded, and with it, a growing mix of hype, fear, and misinformation that is pushing some patients and clinics toward unapproved, higher-risk options
He previously spent more than 17 years at Microsoft, holding leadership roles across Customer Success, global support, and enterprise sales strategy, and managing teams across multiple continents
Its our primary foundation